Mark Snyder

Mark Snyder

Auto-generated profile, based on publicly available information

Mark Snyder

University of Minnesota

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2008 in Social Issues and Policy Review
Verified
Journal Article
Closed access
PDF file
MSMark Snyder
Mark Snyder
AOAllen M. Omoto
Allen M. Omoto

12 October 2010 in Journal of Personality
Verified
Journal Article
Closed access
PDF file
AOAllen M. Omoto
Allen M. Omoto
MSMark Snyder
Mark Snyder
JHJustin D. Hackett
Justin D. Hackett


11 February 2012
Verified
Conference Paper
Open access
PDF file
PFPaul Fugelstad
Paul Fugelstad
PDPatrick Dwyer
Patrick Dwyer
JMJennifer Filson Moses
Jennifer Filson Moses
JKJohn Kim
John Kim
CMCleila Anna Mannino
Cleila Anna Mannino
MSMark Snyder
Mark Snyder
Administrators of online communities face the crucial issue of understanding and developing their user communities. Will new users become committed members? What types of roles are particular individuals most likely to take on? We report on a study that investigates these questions. We administered a survey (based on standard psychological instruments) to nearly 4000 new users of the MovieLens film recommendation community from October 2009 to March 2010 and logged their usage history on MovieLens. We found that general volunteer motivations, pro-social behavioral history, and community-specific motivations predicted both the amount of use and specific types of activities users engaged in after joining the community. These findings have implications for the design and management of online communities.


3 February 2021 in Pharmacy
Verified
Journal Article
Open access
PDF file
KIKamla M. Ibrahim
Kamla M. Ibrahim
Jon SchommerJon Schommer
Jon Schommer
DMDonald Morisky
Donald Morisky
RRRaquel Rodriguez
Raquel Rodriguez
CGCaroline Gaither
Caroline Gaither
MSMark Snyder
Mark Snyder
This cross-sectional study aimed to describe the association between medication experiences and beliefs and self-reported medication adherence in patients with chronic diseases in two different samples from two different societies: the USA and the Sultanate of Oman. The Morisky Medication Adherence Score (MMAS-8) questionnaire was used to measure medication adherence. Three items (statements) were used for measuring medication experiences and beliefs variable on a four-point Likert scale adapted from the 2015 National Consumer Survey of the Medication Experience and Pharmacists’ Role (NCSME&PR). In the U.S., quantitative secondary data analysis of 13,731 participants was conducted using the 2015 NCSME&PR, a self-administered online survey coordinated by Qualtrics Panels between 28 April 2015 and 22 June 2015. The same variables were translated into Arabic, with studies conducted at the Royal Court Medical Center in Oman, and data from 714 participants were collected between 16 June 2019 and 16 August 2019. Data were analyzed using IMB/SPSS version 24.0 software. Chi-square analysis and descriptive statistics were used. The results showed that the low adherence rates for medication (MMAS-8 < 6) were 56% and 52% in Omani and U.S. groups, respectively. Approximately 90% of the U.S. and Omani participants believed that “medicines are a life-saver”; however, medication adherence was higher in Oman (30%) than in the United States (9%) for these participants. In total, 60% of the U.S. and 29% of Omani participants believed that “medicines are a burden”; however, about 60–65% of participants in both countries were in the low medication adherence group. Additionally, 63% of the U.S. and 83% of the Omani participants disagreed that “medicines do more harm than good”; however, medication adherence in the U.S. (15%) was higher than in Oman (8%). In conclusion, a decrease in low medication adherence was observed with positive medication experiences and beliefs. However, the impacts of medication experiences and beliefs on low medication adherence rates were different from one population to another. The “medication burden” statement resulted in the highest percentage of difference in terms of low medication adherence rates between those who agree and those who disagree in the U.S. group (20%), whereas the “medicines are a life-saver” statement resulted in a greater difference in the Omani group (30%). Proper communication between patients and healthcare providers based on the patient’s medication experiences and beliefs will substantially improve medication adherence.